Managing Changing Paradigms in Health Products Regulation |

Managing Changing Paradigms in Health Products Regulation


Health products that include medicinal drugs, medical devices and complementary health products are a critical component of all healthcare systems. Regulators of these products are operating in a fast changing landscape shaped by globalisation, scientific and technological advancements, and rising stakeholder expectations. Worldwide, national regulatory agencies must continue to assure the safety, quality and efficacy of health products in the face of complex supply chains, novel and combination products falling outside the ambit of traditional frameworks, and meeting societal and patient demands for greater transparency and faster access to new therapies. At the same time, all agencies face resource and expertise constraints. Regulators must develop responsive and robust regulatory frameworks to better manage uncertainty, accommodate innovative health products without impeding access, and promote harmonization, is must be done while fulfilling their fundamental mandate to safeguard public health.

In this session, Dr John Lim, CEO of Singapore’s Health Sciences Authority will discuss the agency’s approaches to managing risk-based regulatory paradigms that accommodate innovation and facilitate timely access to safe, high quality and efficacious health products for patients and consumers.


Dr John CW Lim, CEO of Singapore’s Health Sciences Authority, Singapore

Wednesday, 09 April 2014
12:15 p.m. - 1:30 p.m.

Seminar Room 3-5,
Manasseh Meyer,
Lee Kuan Yew School of Public Policy,
469C Bukit Timah Road,
Singapore 259772

Seats are limited and will be available on a first-come, first-served basis. Kindly register your interest online.

WordPress Video Lightbox Plugin